Skip Navigation


ToxSci Advance Access originally published online on September 22, 2007
Toxicological Sciences 2007 100(2):513-524; doi:10.1093/toxsci/kfm233
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/2/513    most recent
kfm233v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knight, T. R.
Right arrow Articles by Klaassen, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, T. R.
Right arrow Articles by Klaassen, C. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Constitutive mRNA Expression of Various Glutathione S-Transferase Isoforms in Different Tissues of Mice

Tamara Raphael Knight1, Supratim Choudhuri2 and Curtis D. Klaassen3

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160

3 To whom correspondence should be addressed at Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160-7417. Fax: (913) 588-7501. E-mail: cklaasse{at}kumc.edu.

Received April 18, 2007; accepted August 31, 2007


   Abstract

Glutathione S-transferase (Gst) enzymes are instrumental in protecting cellular macromolecules against electrophiles and products of oxidative stress. Of interest primarily to pharmacologists and toxicologists is the ability of these enzymes to metabolize cancer chemotherapeutic drugs, insecticides, herbicides, and carcinogens. Thus, constitutive expression of Gsts might determine a tissue's ability to handle certain forms of chemical stress. In the present study, the constitutive mRNA expression of 19 different Gst enzymes was investigated in 14 different tissues in mice. The information obtained from the present study could be distilled into a few generalized principles: in all tissues examined, multiple isoforms of Gst were constitutively expressed; several isoforms, such as Gstk1, Gstm1, Gstm4, Gstm6, and Gstt1, were expressed in most of the tissues studied; at least five Gst isoforms were highly expressed in the gonads, about three in heart, and at least one in brain (Gstm5). Gender differences in the expression of various Gst isoforms were pronounced. With a few exceptions, most of the Gst isoforms expressed in kidney showed higher expression in females than males; the same trend was observed for heart and gonads. At least eight Gst isoforms showed very high expression in stomach. This was a unique finding in the current study because drug-metabolizing enzymes that are highly expressed in the gastrointestinal (GI) tract tend to have the highest expression in small intestine with low or no expression in the stomach. In summary, most Gst isoforms are most highly expressed in the GI tract and liver, which strongly suggests an important role of many Gst isoforms in detoxification of ingested xenobiotics.

Key Words: glutathione transferase; Gst; tissue distribution; mRNA; bDNA.


Disclaimer: The opinions expressed in this article are the authors’ personal opinions and do not necessarily reflect those of Food and Drug Administration, Department of Health and Human Services, or the Federal Government.

1 Center for Toxicology and Environmental Health, L.L.C., Little Rock, Arkansas 72201.

2 Food and Drug Administration, Center for Food Safety and Applied Nutrition, OFAS/DBGNR, College Park, Maryland 20740.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. J. Waxman and M. G. Holloway
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Mol. Pharmacol., August 1, 2009; 76(2): 215 - 228.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. R. Hayes, B. M. Young, and M. T. Pletcher
Expression Quantitative Trait Loci Mapping Identifies New Genetic Models of Glutathione S-Transferase Variation
Drug Metab. Dispos., June 1, 2009; 37(6): 1269 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. R. Knight, S. Choudhuri, and C. D. Klaassen
Induction of Hepatic Glutathione S-Transferases in Male Mice by Prototypes of Various Classes of Microsomal Enzyme Inducers
Toxicol. Sci., December 1, 2008; 106(2): 329 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Tanaka, L. M. Aleksunes, R. L. Yeager, M. A. Gyamfi, N. Esterly, G. L. Guo, and C. D. Klaassen
NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 655 - 664.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.